PrEP and PEP are medical prevention approaches that help reduce the risk of HIV infection. Both involve antiretroviral medications, but they are used at different stages of potential exposure. PrEP is taken before possible exposure, while PEP is used after a potential exposure and requires prompt medical attention. Understanding their purpose, timing, and appropriate use can help individuals make informed decisions about HIV prevention. These options should be discussed with qualified healthcare professionals to determine suitability, testing requirements, and follow-up care.
PrEP stands for pre-exposure prophylaxis, while PEP means post-exposure prophylaxis. Both approaches use medication to help prevent HIV infection, but the timing and circumstances of use differ.
PrEP is intended for people who do not have HIV and may face ongoing exposure risks. PEP is an emergency prevention option for people who may have been exposed to HIV recently.
Key differences include:
PrEP helps prevent HIV from establishing infection when medication is taken according to the prescribed regimen. It may be considered for individuals who have ongoing potential exposure through sexual activity or other circumstances identified by a healthcare professional.
Different PrEP options are available, including oral medication and long-acting injectable formulations in appropriate settings. The choice depends on individual circumstances, medical assessment, and available treatment options.
Important considerations for PrEP include:
PrEP does not treat an existing HIV infection. HIV testing and clinical evaluation are important before and during its use.
PEP is designed for emergency situations in which a person may have been exposed to HIV. Potential exposure can occur through certain sexual activities, sharing injection equipment, or other situations involving potentially infectious body fluids.
PEP timing and treatment considerations include:
PEP is not intended to replace regular HIV prevention methods for people experiencing frequent exposure risks. Individuals with ongoing potential exposure may benefit from discussing PrEP with a healthcare professional.
HIV testing is an important part of both PrEP and PEP care. Healthcare professionals use testing to assess HIV status, determine appropriate prevention options, and plan follow-up evaluations.
People who begin PEP should not delay seeking medical care while waiting to arrange all test results. Clinical guidance recommends that the first dose should not be delayed while awaiting certain laboratory results when PEP is indicated.
Other prevention strategies, including condom use, testing for sexually transmitted infections, and appropriate medical counseling, can support broader sexual health management.
PrEP and PEP provide different approaches to HIV prevention. PrEP supports prevention before potential exposure, while PEP is an urgent option after a qualifying potential exposure. Understanding the differences, seeking timely medical advice, and following recommended testing and medication instructions can help individuals make informed decisions about their health. These prevention options should be considered alongside professional medical guidance and appropriate follow-up care.